Teoh, Lay Sin
Guiraud, Vincent
Ong, Haris
Du, Yang
Zhao, Zhihai
Gautheret-Dejean, Agnès
Xu, Na
Article History
Received: 31 October 2023
Accepted: 21 August 2024
First Online: 26 August 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: The study complied with the requirements of local ethics, biosafety and investigation committees and the purchased human serum and plasma specimens were controlled under Singapore BATA Act. The acquirement, handling and storage of human blood samples were approved by Minister of Health in Singapore. All experimental protocols were approved by MP Biomedicals Asia Pacific Pte Ltd. The informed consent was obtained from all subjects and/or their legal guardian(s), if applicable.For serum samples processed in France, in accordance with the French legislation, this study was registered to the French authorities under the number 20240202101810 by the Data Protection Officer of the Pitié-Salpêtrière Hospital using the MR-004 referral methodology of the “Commission Nationale de l’Informatique et des Libertés”. Patients were systematically notified of any supplementary biological analyses on frozen samples, initially collected as part of routine clinical practice.